Life after cancer treatment: what the evidence says about survivorship

The word "survivor" is now used from the day of diagnosis onward, and the population it describes is large and growing. More than 18 million Americans with a history of cancer were alive at the start of 2022 — 8.3 million men and 9.7 million women [s1]. As screening and treatment have improved, so has the odds of joining them: the overall five-year relative survival rate for all cancers combined is now 68 percent [s3]. But finishing treatment is not the same as returning to where a person started, and survivorship has become its own field of medicine precisely because the health story continues.

Who survivors are

The population is more varied than the stereotype of a recent patient. More than half of survivors — 53 percent — were diagnosed within the past 10 years, but the rest are living years or decades beyond treatment, and two-thirds, 67 percent, are aged 65 or older [s1]. That mix matters, because a person five years out from breast cancer and a person six months out from a stem-cell transplant face very different issues, and both are counted as survivors.

The long tail of treatment

The central fact of survivorship is that cancer treatment can leave lasting effects. Survivors often experience declines in physical functioning and quality of life, and, compared with people who have not had cancer, face an increased risk of recurrence and of all-cause mortality [s2]. Cancer-related and treatment-related side-effects — the physical and psychological legacy of surgery, chemotherapy, radiation and newer therapies — are a recognised part of the picture that survivorship care exists to address [s1]. These range from persistent fatigue and pain to organ effects, second cancers, and the psychological weight of fear of recurrence.

Survivorship care is also where cancer's inequities persist. The statistics report documents large racial disparities in treatment itself: for stage I rectal cancer, 41 percent of Black patients received surgery to remove the tumour, compared with 66 percent of White patients; for early-stage non-small cell lung cancer, surgery was received by 49 percent of Black patients versus 55 percent of White patients [s1]. Differences like these compound over the years that survivorship spans.

What the evidence says actually helps

Against a problem this broad, the intervention with the strongest evidence is strikingly plain: physical activity. An international expert roundtable convened by the American College of Sports Medicine concluded that exercise training and testing are generally safe for cancer survivors, and that every survivor should avoid inactivity [s2]. It found enough evidence to conclude that specific doses of aerobic exercise, resistance training, or a combination could improve several of the most common survivorship problems — anxiety, depressive symptoms, fatigue, physical functioning, and health-related quality of life [s2]. It was candid about the limits, too: for some outcomes, such as chemotherapy-related peripheral neuropathy and cognitive function, the evidence remained uncertain [s2].

The American Cancer Society's survivorship guideline extends the same logic to diet and weight, concluding from laboratory and observational studies that diet, physical activity and obesity may affect the risk of recurrence and overall survival after a cancer diagnosis [s3]. The evidence base there is largely observational rather than from randomised trials, which the guideline is careful to note — but the direction is consistent, and the recommended behaviours carry little downside.

What this means for a reader

For someone who has finished cancer treatment, the evidence supports two ideas at once. First, ongoing care matters: survivorship involves real, sometimes delayed effects, which is why structured follow-up, monitoring for recurrence and second cancers, and attention to mental as well as physical health are part of good care rather than an afterthought. Second, the single best-supported thing a survivor can do for their own recovery is to be physically active within their ability, because the evidence that exercise improves fatigue, mood, function and quality of life is among the strongest in the field [s2]. What that looks like in practice — how much, what kind, and when after treatment — should be worked out with the clinical team, particularly for survivors with lasting treatment effects. The general message is not a prescription; it is that life after treatment is something the evidence says can be actively improved.

Sources

• [s1] Cancer treatment and survivorship statistics, 2022, CA: A Cancer Journal for Clinicians, 2022-06-23
• [s2] Exercise Guidelines for Cancer Survivors: Consensus Statement, Medicine and Science in Sports and Exercise, 2019-11-01
• [s3] American Cancer Society nutrition and physical activity guideline for cancer survivors, CA: A Cancer Journal for Clinicians, 2022-03-16